Patent

AA Thornton’s AI experts contributed to the UK government review of artificial intelligence and intellectual property and have been monitoring developments. Mike Jennings and LLoyd Palmer provide this summary of recent government progress The UK Government has published the responses it received to its 2020 “Call for views on AI and IP” and published its… Read more »

Amgen v Sanofi and Regeneron: Broad antibody patents held invalid for lack of enablement in US Lack of enablement: A conclusion of lack of enablement means that the disclosure provided in the patent specification, at the time the application was filed, would not have taught one skilled in the art how to make and/or use the full… Read more »

Partner Dr. Lawrence King reflects on Patenting in the Pandemic and the importance of locking down innovation in troubled times in this article, first published in The Chemical Engineer. The importance of locking down innovation in troubled times TO MOST, A Poor Man’s Tale of a Patent, published in October 1850, remains one of Charles Dickens’ lesser-known… Read more »

Partners Mike Jennings and Alex Bone explore the UKIPO “Green Channel” At AA Thornton, our patent attorneys have a long history of assisting innovators seeking protection for a variety of green technology including solar technology, waste processing and wind turbines.  Some of our clients were kind enough to share their stories with us, and you… Read more »

As the world faces unprecedented challenges caused by the SARS-Cov-2 virus, we look at the science behind vaccine technology being investigated and how intellectual property (IP) rights may play a part in its protection. This article was first published by BioScience Today and can be found here.   What is a Vaccine? The immune system… Read more »

Is your IP Strategy fit for purpose? – Five Questions to Ask Yourself The following article was first published in issue 21 of BioScience Today.   As a result of the lockdown due to the global pandemic there is a greater need and renewed focus on using innovation to kick-start the economic recovery.  The result… Read more »

Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools and Beyond This article was first published in BioScience Today The pharmaceutical and healthcare industry is often accused of misusing IP to extend exclusivity and delay reasonably priced access to life saving technologies. The recent pandemic has focussed attention on the… Read more »

An interview with Mike Jennings of AA Thornton – Patenting AI and computer simulation Partner Mike Jennings is a regular speaker on patenting computer-implemented inventions (CIIs).  In this interview, we asked Mike for an update on European patenting of artificial intelligence and computer simulation. AA Thornton has a substantial practice protecting CIIs.  Clients include some… Read more »

Tackling the stigma of disability in IP: exclusive interview with IP Ability co-chairs This article is a summary of the full article, by the same name, first posted by the World Trade Mark review, that can be found here.   Marianne Privett, AA Thornton’s Diversity & Inclusion Partner, and Francesca Rivers a Solicitor at Cancer… Read more »